CareTrust REIT, Inc. (CTRE) Guidance & Earnings Results

On 2026-08-06 CareTrust REIT, Inc. raised guidance: "Normalized FFO $2.03-$2.06 per share; Normalized FAD $2.01-$2.04 per…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CTRECareTrust REIT, Inc.Follow CTRE — free

REIT - Healthcare Facilities · Real Estate

—

Price chart with a free account

Market cap: 8.7B
P/E TTM: 22.9
Dividend yield: 4.0%
52-week: —
Next earnings: 11 Nov, in 18 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Raised	Normalized FFO $2.03-$2.06 per share; Normalized FAD $2.01-$2.04 per share · full year
7 May 26	Raised	Normalized FFO guidance midpoint $2.02 (14.8% YoY growth); Normalized FAD guidance midpoint $2.00 (13.6% YoY growth). · full year
12 Feb 26	Raised	Normalized FFO guidance midpoint $1.925, up 9.4% YoY
5 Nov 25	Raised	Net income $1.41-$1.42, normalized FFO $1.76-$1.77, normalized FAD $1.76-$1.77 per share · full year
6 Aug 25	Raised	FY25 net income per share $1.43-1.45; FY25 Normalized FFO per share $1.77-1.79; FY25 Normalized FAD per share $1.77-1.79; based on 195.3M diluted shares; assumes no new investments, no new debt/equity, 2.5% CPI escalators · full year

CareTrust REIT, Inc. — questions

What guidance did CareTrust REIT, Inc. give?: On 2026-08-06: "Normalized FFO $2.03-$2.06 per share; Normalized FAD $2.01-$2.04 per share"
When does CareTrust REIT, Inc. report earnings?: CareTrust REIT, Inc.'s next earnings report is expected on 2026-11-11.

Every figure on this page comes from CareTrust REIT, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.